- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05951257
Medical Hypnosis and Music for Palliative Care (MuzhypforPC)
Feasibility and Efficacy of Hypnosis and Music on Pain, Anxiety and Well-being in End-of-life Palliative Care at Home
The goal of this randomized controlled trial is to evaluate the efficacy of a personalized multimodal intervention program (MuzHyp) including hypnosis, music or their combination to improve palliative care at home.
The main objective is to evaluate if the intervention program will significantly reduce participants' composite score of pain, anxiety, and unwellness as evaluated by the Edmonton symptom assessment scale (ESAS) immediately after the intervention, and whether this improvement will be significantly greater than that of control sessions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Context :
Quality of life at home in end-of-life palliative care is an ideal that is often difficult to achieve. Side effects of medications and limited access to resources and services can affect the control of pain, anxiety and well-being. Research shows that musical interventions and the use of medical hypnosis can help reduce pain and anxiety, and thus improve patients' psychological well-being in many clinical settings. In view of this, we have developed an intervention program combining medical hypnosis and music (Bissonnette et al., 2022; https://www.frontiersin.org/articles/10.3389/fpain.2022.926584/full).
Objectives and study design :
The main objective of this randomized control trial is to evaluate the efficacy of a personalized multimodal intervention program including hypnosis, music or their combination on composite score of pain, anxiety and unwellness as evaluated with the ESAS.
The secondary objectives are to assess :
- The evolution of distress and of each of the ESAS variables (pain, fatigue, nausea, depression, anxiety, sleepiness, appetite, unwellness, breathlessness) from pre-test to post-test compared with changes in these variables in the control group.
- The preference for the intervention modality (hypnosis, music or their combination).
- The feasibility of the experimentation in end-of-life palliative care at home.
- The experiential dimensions associated with music and hypnosis
- The subjective experience of the intervention.
Description of interventions :
The intervention program consists of a personalized multimodal intervention involving hypnosis and music. It offers each participant the option to receive (a) the hypnosis intervention presented as guided imagery, (b) the music intervention, or (c) a combination of (a) hypnosis (guided imagery) and (b) music. Each intervention is further personalized by integrating individually preferred imagery and/or music.
Recruitment and allocation procedure :
Adults (n = 40) in palliative home care receiving home support services from CIUSSS-NIM or CISSS-CA and meeting the inclusion criteria are eligible to participate in the project. The clinical team identifies participants who meet the selection criteria and asks them if they would like a visit from a member of the research team. During this visit, each participant is informed of the project and asked to sign the consent form. All participants then choose their preferred intervention modality (a. hypnosis, b. music or c. combination of hypnosis and music) before completing baseline measures including a socio-demographic questionnaire, the ESAS and a distress measure. Participants who choose an intervention with music (modalities a and c) are asked to identify pieces that they expect will generate positive emotions. Participants who choose guided imagery (modalities b and c) are asked to describe a pleasant place.
Participants are then stratified by gender and randomly assigned to the "experimental" group and the "control/waiting list" group. The distribution follows the order previously determined by a random table generated using an Excel function.
Two sessions are offered to the participants of the experimental group. During the sessions, a facilitator takes the pre-interventions measurements (see below), asks the participants to listen to the recorded intervention of 15 to 25 minutes by themselves while he/she waits outside the participant's home, and then comes back to fill in the post-intervention measurements (see below). Participants are also asked to report how they feel after each intervention and are given a brief semi-structured interview about their subjective experience.
Procedure in the two intervention sessions:
- Measures (ESAS; Distress) (3-5 min)
- Intervention Sessions (15-25 minutes)
- Measures (ESAS; Distress; Experiential dimensions) (3-5 minutes)
- Semi-structured interview about the subjective experience (2-5 min)
Participants in the control/waiting list group receive two control sessions following the same procedure as the experimental group but without receiving the intervention. During these control sessions, the same distress and ESAS measures are taken at 20-minute intervals. In the meantime, participants continue to perform their usual daily activities by themselves while the experimenter walk outside the participant's home.
Plan for each control session:
- Measures (ESAS; Distress) (3-5 min)
- Usual Daily Activities (20 min)
- Measures (ESAS; Distress) (3-5 min)
After the two control sessions are completed, participants in the control/waiting list group receive two intervention sessions, following the same procedure as the experimental group. These supplementary sessions are not part of the main analysis design but will be examined as they provide additional pre-post intervention data.
Main objective:
To analyze the changes in the composite score of pain, anxiety, and unwellness between the beginning and the end of the sessions as a function of the group (control/waiting list vs. experimental), a mixed model repeated measures analysis procedures will be performed using SPSS software (GLM model). Data from all participants who completed at least one session will be retained and included in the analyses. Missing scores will be imputed by the model. We have also planned a sensitivity analysis taking into account the baseline level of the dependent variables, if there is a risk of a floor effect.
The data acquired in the additional sessions for the control group will be analysed separately and compared to the pre-post data obtained in sessions 1 and 2 in the same participants and in the experimental group.
The secondary objectives:
To assess the evolution of distress and of each of the ESAS variables of the experimental group from pre- to post-intervention and to evaluate the composite score for the intervention sessions in the control/ waiting list group we will apply a similar GLM model.
To assess the preference of the intervention modality (hypnosis, music, or hypnosis and music), we will count the frequency of selection of each intervention modality for all participants.
To assess the experiential aspects of the intervention, we will calculate the mean for each of the eight experiential dimensions.
To explore the subjective experience of the intervention, two open questions will be asked by the facilitator to inquire about the participant's current feeling and about their impression of change.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada
- Ciusss-Nim
-
Saint-Georges, Quebec, Canada
- CISSS-CA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- End-of-life palliative care at home
- Between 30% and 79% on the Karnofsky Performance Index
- With adequate communication skills to complete the steps of the research
- With satisfactory or corrected hearing, as recommended by the caregiver.
- Severe neurocognitive or psychotic disorders
Exclusion Criteria:
- Severe neurocognitive or psychotic disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Personalized multimodal intervention involving hypnosis and/or music
This arm will receive a personalized multimodal intervention involving (a) hypnosis, (b) music or (c) hypnosis and music. Note that the objective of the research is not to compare the effect of the different intervention modalities between them, but to consider these three modalities as a multimodal intervention taking into consideration patients' preferences, that we compare to the control. |
The three intervention modalities (music and/or hypnosis) will begin by a moment of relaxation in which we will ask the participants to focus their attention on their breathing, on relaxation and on the process of absorption into oneself.
The hypnosis modality consists in visiting in imagination a pleasant place that the participant will choose and to live some metaphorical stories.
The "musical" modality consists of listening to one or two pieces of music chosen by each participant and which brings him/her well-being, according to them.
These two types of work will be preceded by a moment of relaxation in which we will ask the participants to focus their attention on their breathing, on relaxation and on the process of absorption into oneself.
Other Names:
|
|
No Intervention: Control/Waiting list
The participants of the control group will carry out its their daily activities and will be assessed using the same measures, at the beginning of each session and after a delay comparable to the duration of the intervention administered in the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Composite pain, anxiety, and unwellness score
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in composite outcome score for pre-test to post-test for the experimental sessions compared with change in the control group.
The composite score will be obtained by summing the pain (0-10), anxiety (0-10) and unwellness scores (0-10) from the Edmonton Symptom Assessment Scale.
(ESAS)
|
The posttest was administered 25 minutes after the pretest.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Pain levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in pain level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Anxiety levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in anxiety level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Unwellness levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in unwellness level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Fatigue levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in fatigue level, as assessed by the Edmonton symptom assesment scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Nausea levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in nausea level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Depression levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in depression level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Sleepiness levels
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in sleepiness level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Appetite
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in appetite level, as assessed by the Edmonton Symptom Assesment Scale (ESAS) on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Changes in Distress
Time Frame: The posttest was administered 25 minutes after the pretest.
|
Change in distress level, as assessed by a Distress Thermometer on a scale of 0 to 10.
|
The posttest was administered 25 minutes after the pretest.
|
|
Preference of the intervention modality
Time Frame: At baseline
|
The preference of the intervention modality by calculating the selection frequency (and the percentage) of each intervention across all participants.
|
At baseline
|
|
Experiential dimensions
Time Frame: 1 week
|
Ratings (0-10) obtained to characterize a) the participant's experience of mental absorption, b) change in perspective, c) experience of reminiscence, d) feeling of being understood, e) experience of transcendence, f) somatic experience, g) feeling of being in control
|
1 week
|
|
Feasibility of the study
Time Frame: Through study completion, an average of 1 year.
|
To conduct the feasibility study, we will look at 1) the number of patients who have expressed initial interest in the study; 2) the number of participants recruited per month, 3) the proportion of patients who participate in the study out of the number of people in palliative home care for the entire experimental period, 4) the proportion of patients who complete the study.
|
Through study completion, an average of 1 year.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective experience
Time Frame: 1 week
|
Two open questions will be asked by the facilitator to inquire about the participant's current feeling (How do you feel?) and about their impression of change (What is different now compared to the beginning of the session?).
The answers will be audio-recorded or noted by the facilitator.
|
1 week
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Josiane Bissonnette, Ph.D, Laval University
Publications and helpful links
General Publications
- Bissonnette J, Pierre S, Duong ATJ, Pinard AM, Rainville P, Ogez D. Development of a Mixed Hypnosis and Music Intervention Program for the Management of Pain, Anxiety, and Wellbeing in End-of-Life Palliative Care. Front Pain Res (Lausanne). 2022 Jul 6;3:926584. doi: 10.3389/fpain.2022.926584. eCollection 2022.
- Bissonnette J, Dumont E, Pinard AM, Landry M, Rainville P, Ogez D. Hypnosis and music interventions for anxiety, pain, sleep and well-being in palliative care: systematic review and meta-analysis. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e503-e514. doi: 10.1136/bmjspcare-2022-003551.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP-23-2022-896
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States